Gary A. Dahl

Statistics

Publications

Citations

498

H-Index

Active since

1978

Affiliations

National Institute of Allergy and Infectious Diseases(Current)

National Institutes of Health

Harvard University

St. Jude Children's Research Hospital

Leidos (United States)

Gary A. Dahl is an author at National Institute of Allergy and Infectious Diseases specializing in life sciences, therapeutic genome editing, and genome editing.

Publications per year

1978–2025

Publications

Vinyl carbamate as a promutagen and a more carcinogenic analog of ethyl carbamate.

Gary A. Dahl, James A. Miller, Elizabeth C. Miller · PubMed · 1978 · 127 citations

Pharmacy, Pharmacology, Toxicology +16

Comparative carcinogenicities and mutagenicities of vinyl carbamate, ethyl carbamate, and ethyl N-hydroxycarbamate.

Gary A. Dahl, Elizabeth C. Miller, James A. Miller · PubMed · 1980 · 86 citations

Medicine, Pharmacology, Toxicology +8

Enhanced homology-directed repair for highly efficient gene editing in hematopoietic stem/progenitor cells

Suk See De Ravin, Julie Brault, Ronald J. Meis et al. · Blood · 2021 · 74 citations · Full text

Life Sciences, Genetics, Molecular Biology +14

Custom CRISPR–Cas9 PAM variants via scalable engineering and machine learning

Rachel A. Silverstein, Nahye Kim, Ann-Sophie Kroell et al. · Nature · 2025 · 61 citations · Full text

Life Sciences, Biotechnology, Genetics +13

Correction of X-CGD patient HSPCs by targeted CYBB cDNA insertion using CRISPR/Cas9 with 53BP1 inhibition for enhanced homology-directed repair

Colin L. Sweeney, Mara Pavel-Dinu, Uimook Choi et al. · Gene Therapy · 2021 · 52 citations · Full text

Life Sciences, Genetics, Molecular Biology +16

1–5 of 9